America's Top Tradeshow Directory | Events In America
Facebook Linked In Twitter Videos

Event Contacts

Help Desk
1235 Bay Street
Toronto, ON M5R 3K4
(416) 977-6555

Event Description

Before being used in humans, medical devices need, in general, to have some testing performed in order to assess their safety profile. This biocompatibility assessment includes various endpoints, among which a certain number are focused on the potential effect on blood - also known as hemocompatibility.

Even within the cardiovascular field, the type of blood contact may vary from non-contact, indirect, external communicating with direct contact, or for implanted devices. Official guideline documents such as ISO 10993-4, provide direction for deciding whether testing for interaction with blood is necessary. Complex phenomenon such as the hemostasis can be best monitored in-vivo, with the device used the way it is intended. When testing is performed in-vitro, an appropriate model or system should be used that simulates closely enough the clinical situation, so that these pre-clinical results possess enough predictive value. The appropriate choice of controls, as well a clear identification of the test article, (or the part(s) thereof), is also critical as part of a proper strategy to allow smooth regulatory review such as 510K or CE mark.
Both in-vitro and in-vivo models can be used for this purpose, each being set up with the goal of mimicking clinical application and allowing assessment of the proper end-point.

Whether the blood contact is direct or indirect, each device needs to be considered for their hemocompatibility, such as hemolysis, thrombosis, platelet activation, hematology and complement activation.

This webinar will present various aspects of hemocompatibility testing: selection of tests, identification of what devices need to be tested and what part of the device needs testing. It will also cover some technical details about how the various tests function: chemically and mechanically induced hemolysis, pro-coagulant effect, effect on platelets and leukocytes, and activation of the complement.

Devices that are involved in the circulation of blood, like cardiopulmonary bypass systems or apheresis equipment, may compromise hemocompatibility, damaging the red blood cells by mechanical means. Other devices may manifest some hemolytic potential via their chemical composition, either as extractable or leachable, or by direct contact of the red blood cells with the device.

As foreign materials, medical devices can activate the coagulation cascade. The resulting thrombus, either on the surface of the devices or dislodged, may be the source of serious complications. Some membranes used in hemodialysis have been linked to complement activation, leading to pulmonary distress and coagulation disorders.

A proper selection of the most applicable tests is therefore essential to detect and predict any deleterious interaction between the devices and the blood.

Not sure if you want to exhibit at or attend the Hemocompatibility: Preclinical Biological Evaluation of Medical Devices for Interaction with Blood? See the panels below to get the information you need to make an informed decision.

All information in Events In America is deemed to be accurate at the time we add it, and we take steps to verify all details and update our records when new information is provided, but as people, events and circumstances change, we caution users to independently confirm all information. and Events In America LLC make no guarantee of accuracy and assume no liability for inaccurate information.

Event Details

Conference/Event Dates: 06/29/2016 - 06/29/2016
Classification: B2B
Primary Industry: Medical
Other Industries: Manufacturing, Medical, Pharmaceutical, Professional Healthcare
Audience: Senior level executives involved in regulatory affairs for medical device companies, including those from manufacturing services providers, consulting companies, product development, and financial/investment companies and government.

Relevant job functions include:

Engineering - Biomedical, Design, Manufacturing/Production, Packaging, Process, Project, Quality, R&D
Manufacturing (Packaging, Process)
Project Management
Research & Development
Regulatory / Compliance / Quality Assurance
Sales / Business Development / Marketing

The session will also benefit pharmaceutical, biotechnology and dental product manufacturers.

Booth Details

Booth Size Booth Cost   Available Amenities
No exhibiting.   Electricity: n/a
  Water: n/a
  Generator: n/a
  Marketing Vehicles Allowed: n/a
Other Booth Sizes Available: n/a

Advance Networking

How do I show up here?
Mark Travers

Personal Notes

Add a note here, it is only visible by you.

New Search Contact This Event
Hemocompatibility:  Preclinical Biological Evaluation of Medical Devices for Interaction with Blood

exhibitor lists